Potency preparations accounted for the maximum of the illegally imported substances that were confiscated in 2016 by Swiss customs officials, the latest annual data showed.
This comes amid a continuing global clampdown on illicit wealth allegedly stashed in Swiss banks, including by Indians.
Also Read
This is the second year in a row that India remained the top source of such illegal imports into Switzerland. However, the figure was lower at 42 per cent in 2015.
At the request of Swissmedic, the customs department seized 1,028 shipments of illegally imported therapeutic products in 2016.
"Potency preparations remain at the top of the list of illegally imported substances, followed by medicines with the potential for dependence (psychotropic agents, sleeping tablets and tranquillisers) and other medically important drugs.
"Nearly half of all shipments originated from India," Swissmedic said in a release on Tuesday.
Among the confiscated shipments, 55 per cent were erectile stimulants while sleeping tablets and tranquilisers accounted for 13.5 per cent.
As many as 13 per cent of such shipments were "medically important, prescription only medicines". Slimming preparations and hair growth preparations made up for five per cent and 2.5 per cent, respectively, the data showed.
"The unauthorised import and use of prescription-only medicines such as sleeping tablets or antibiotics represents a risky practice from the perspective of health.
"Particularly worrying is the number of confiscated medicines for the treatment of acne, which, though still small, rose in 2016," the release said.
After India, the next top source of such illegal imports was Western Europe (The UK, Germany and Portugal), which accounted for 21 per cent of such shipments.
Around 13 per cent of illegal imports were from Asia, excluding India, while 9 per cent were from Eastern Europe.
Swissmedic said that criminal suppliers on the internet primarily use spam e-mails to advertise their ostensibly serious online shops selling "generic products at advantageous prices".
"Counterfeit medicinal products frequently contain too high or too low a dose, or incorrect, undeclared or even no active substances," the release said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)